- $110.08bn
- $143.19bn
- $8.02bn
- 74
- 35
- 76
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,331 | 4,439 | 4,759 | 5,974 | 8,023 |
Cost of Revenue | |||||
Gross Profit | 2,412 | 3,269 | 3,511 | 4,465 | 6,013 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,355 | 3,225 | 3,329 | 3,713 | 4,936 |
Operating Profit | 976 | 1,214 | 1,430 | 2,260 | 3,088 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,776 | 1,747 | 3,323 | 3,691 | 3,464 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,702 | 1,617 | 3,149 | 3,555 | 3,253 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,573 | 1,482 | 2,940 | 3,365 | 3,059 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,614 | 1,515 | 3,016 | 3,451 | 3,131 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.23 | 1.37 | 2.21 | 2.87 | 2.67 |
Dividends per Share |